Ai2 Ltd is a UK-based biotechnology company that specialises in novel anti-infective peptide technology which combines potent efficacy with excellent safety. Ai2 is developing this technology for a variety of applications in healthcare and personal care areas where this combination of safety and efficacy can provide significant benefits.
Location: United Kingdom, England
Total raised: $3.09M
Investors 1
| Date | Name | Website |
| - | MTI Partne... | mtiventure... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 06.01.2012 | - | $2.7M | - |
| 08.02.2010 | - | $390.35K | - |
Mentions in press and media 4
| Date | Title | Description |
| 15.11.2022 | New spinout from AI2 lands $4M to quell ICU alarms and make the hospital a quieter place | A CalmWave dashboard. (CalmWave Image) A new startup out of the Allen Institute for Artificial Intelligence (AI2) Incubator raised $4 million to reduce alarms from devices attached to patients in the ICU. CalmWave went from inception to fun... |
| 06.01.2012 | Ai2 Raises £1.75M | Ai2 Limited, a Manchester, UK-based company that has developed proprietary human protein-like substances which inhibit bacteria, fungi and viruses, has raised £1.75m in funding. Backers include managers of The North West Fund for Biomedical... |
| 08.02.2010 | UK, Ai2 Limited Secures £250K Funding from UPF | Ai2 Limited, a Manchester, UK-based developer of innovative technology to prevent infection on a wide range of commonly used medical devices like urinary catheters, stents and wound dressings, received a £250,000 investment from MTI Partner... |
| 09.10.2009 | UK, Manchester-Based Ai2 Receives £100,000 Grant for Research and Development | Ai2, a Manchester, UK-based biotechnology company, received a £100,000 Grant for Research and Development (GRAND), the incentive aimed at helping entrepreneurs and business owners introduce innovative products and processes, including resea... |